Rs 1,800 Puts — 2.4% Below Current Price — Draw 7,274 Contracts on Sun Pharmaceutical Industries Ltd

Put Options Event and Cash Market Context

The most active put strikes for Sun Pharmaceutical Industries Ltd on 25 May 2026 were Rs 1,820 (9,921 contracts), Rs 1,800 (7,274 contracts), and Rs 1,840 (7,061 contracts), all expiring on 26 May 2026. The underlying stock closed at Rs 1,844.50, just 3.73% shy of its 52-week high of Rs 1,916.60. Despite this proximity to a yearly peak, the stock underperformed its sector slightly, declining 0.23% on the day and lagging the Sensex’s 1.12% gain.

The turnover for these put contracts was notable, with Rs 187.08 lakhs at the Rs 1,840 strike and Rs 36.66 lakhs at Rs 1,800, signalling active participation. Open interest (OI) figures show 1,704 contracts at Rs 1,840 and 3,315 at Rs 1,800, indicating that a substantial portion of the traded contracts represent fresh positioning rather than mere rollovers.

The expiry is imminent, just one day away, which often intensifies options activity as traders adjust or close positions. Is this surge in put contracts a sign of protective hedging or a directional bet on a near-term decline?

Strike Price Analysis: Moneyness and Intent

The Rs 1,800 strike sits approximately 2.4% out-of-the-money (OTM) relative to the current price of Rs 1,844.50, while the Rs 1,820 strike is about 1.3% below the market price, making it slightly deeper OTM. The Rs 1,840 strike is almost at-the-money (ATM), just Rs 4.50 below the underlying.

OTM puts close to the current price often serve as insurance for long stock holders, protecting against a modest pullback. The proximity of these strikes to the underlying price suggests that the put activity may be more about hedging existing long positions rather than outright bearish speculation. If the put buyers were purely bearish, one might expect heavier activity in deeper in-the-money (ITM) puts or strikes further below the market price to reflect a more pessimistic outlook.

However, the sizeable volume at the Rs 1,820 strike, which is slightly more OTM, could also indicate some directional positioning, though the overall pattern leans towards protective strategies. How does this strike distribution align with the stock’s recent price action and technical setup?

Interpreting the Put Activity: Hedging, Bearishness, or Put Writing?

Put options inherently carry ambiguous signals. They can represent bearish bets if bought outright, protective hedges if purchased by long holders, or bullish bets if sold (put writing). In this case, the stock’s recent performance and technical indicators provide crucial context.

Sun Pharmaceutical Industries Ltd has been trading above its 20-day, 50-day, 100-day, and 200-day moving averages, though it is slightly below the 5-day average. This positioning suggests a generally bullish medium- to long-term trend with some short-term consolidation. The Rs 1,800 put strike roughly corresponds to a support zone just below the 50-day moving average, consistent with a hedging strategy to protect gains against a mild pullback rather than a bet on a sharp decline.

Put writing is less likely here given the high turnover and open interest at these strikes, which points to active buying rather than premium collection. The ratio of contracts traded to open interest is approximately 2.2:1 at Rs 1,800, indicating fresh buying interest rather than just position adjustments.

While some bearish positioning cannot be ruled out, the data favours the interpretation that the put activity is predominantly protective, shielding long positions from near-term volatility rather than signalling a conviction in a downturn.

Open Interest and Contracts Analysis

The open interest at Rs 1,800 stands at 3,315 contracts, with 7,274 contracts traded on the day. This suggests a significant increase in fresh put positions, as the traded volume more than doubles the existing OI. Similarly, the Rs 1,820 strike shows 2,436 OI against 9,921 contracts traded, again indicating substantial new activity.

Such a surge in fresh put buying close to expiry often reflects traders seeking short-term protection or tactical hedging rather than long-term bearish bets. The Rs 1,840 strike, being ATM, also shows a similar pattern with 1,704 OI and 7,061 contracts traded.

These figures imply that the put market is actively positioning for potential short-term downside risk, but the strikes chosen and the stock’s technical context suggest this is more about risk management than directional conviction.

Cash Market Momentum and Delivery Volume

On the cash market front, Sun Pharmaceutical Industries Ltd has shown resilience, trading near its 52-week high and maintaining levels above key moving averages. Delivery volumes have risen by 21.25% against the 5-day average, with 17.05 lakh shares delivered on 22 May, indicating healthy investor participation.

However, the stock’s slight underperformance relative to the sector and Sensex on 25 May, combined with a minor dip below the 5-day moving average, may have prompted some investors to seek downside protection. The put activity aligns with this cautious stance, as hedging against a short-term pullback while maintaining a bullish medium-term outlook.

Is this cautious positioning signalling a pause in the rally or simply prudent risk management?

Fundamental and Sector Context

Sun Pharmaceutical Industries Ltd remains a large-cap leader in the Pharmaceuticals & Biotechnology sector with a market capitalisation of Rs 4,42,749.28 crores. The company’s fundamentals continue to support its valuation, and it trades near its 52-week high, reflecting sustained investor confidence.

The sector itself has been resilient, with the stock outperforming many peers over the medium term. This backdrop further supports the view that the put activity is more likely hedging than outright bearish speculation, as investors seek to protect gains in a fundamentally sound company.

Conclusion: Protective Hedging Dominates Put Activity

The surge in put contracts at strikes just below the current price of Rs 1,844.50, combined with the stock’s technical strength and rising delivery volumes, points to a dominant interpretation of protective hedging rather than bearish positioning or put writing. The proximity of the Rs 1,800 and Rs 1,820 strikes to the underlying price and their alignment with key moving average support levels reinforce this view.

While some traders may be positioning for a short-term correction, the overall data suggests that the put activity is a prudent risk management tool for long holders rather than a signal of imminent weakness. Should investors consider similar protective strategies or interpret this as a pause in the rally?

53% Discount is LIVE - Get MojoOne + Stock of the Week for 3 Years Start Today